Oxidative Stress in Non-Alcoholic Fatty Liver Disease

被引:31
|
作者
Smirne, Carlo [1 ]
Croce, Eleonora [1 ]
Di Benedetto, Davide [1 ]
Cantaluppi, Vincenzo [1 ]
Comi, Cristoforo [1 ]
Sainaghi, Pier Paolo [1 ]
Minisini, Rosalba [1 ]
Grossini, Elena [1 ]
Pirisi, Mario [1 ]
机构
[1] Univ Piemonte Orientale, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy
来源
LIVERS | 2022年 / 2卷 / 01期
关键词
non-alcoholic fatty liver disease; oxidative stress; antioxidants; metabolic syndrome; inflammation; gut microbiota; mitochondrial dysfunction; lipotoxicity; lipid metabolism; reactive oxygen species; PROLIFERATOR-ACTIVATED RECEPTOR; MAC-2; BINDING-PROTEIN; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GUT-MICROBIOTA; HEPATIC STEATOSIS; MITOCHONDRIAL DYSFUNCTION; HEPATOCELLULAR-CARCINOMA;
D O I
10.3390/livers2010003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which may partly explain why it still remains an orphan of adequate therapies. This review highlights the interaction between oxidative stress (OS) and disturbed lipid metabolism. Several reactive oxygen species generators, including those produced in the gastrointestinal tract, contribute to the lipotoxic hepatic (and extrahepatic) damage by fatty acids and a great variety of their biologically active metabolites in a "multiple parallel-hit model". This leads to inflammation and fibrogenesis and contributes to NAFLD progression. The alterations of the oxidant/antioxidant balance affect also metabolism-related organelles, leading to lipid peroxidation, mitochondrial dysfunction, and endoplasmic reticulum stress. This OS-induced damage is at least partially counteracted by the physiological antioxidant response. Therefore, modulation of this defense system emerges as an interesting target to prevent NAFLD development and progression. For instance, probiotics, prebiotics, diet, and fecal microbiota transplantation represent new therapeutic approaches targeting the gut microbiota dysbiosis. The OS and its counter-regulation are under the influence of individual genetic and epigenetic factors as well. In the near future, precision medicine taking into consideration genetic or environmental epigenetic risk factors, coupled with new OS biomarkers, will likely assist in noninvasive diagnosis and monitoring of NAFLD progression and in further personalizing treatments.
引用
收藏
页码:30 / 76
页数:47
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224
  • [22] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
  • [23] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [24] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [25] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [26] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [27] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [28] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [29] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [30] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683